drugset / Trial / NCT00140023
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study will assess the clinical efficacy at Day 14-21 (Test of Cure), 14-21 days after starting the study drug; those subjects from whom a baseline pathogen is identified will also be assessed for bacteriologic response. All subjects who receive 1 dose of study medication will be assessed for safety.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2006-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | — | — |